{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:02:07Z","timestamp":1784739727171,"version":"3.55.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.canlet.2020.12.016","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T05:13:42Z","timestamp":1607577222000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Helper T cells in malignant pleural effusion"],"prefix":"10.1016","volume":"500","author":[{"given":"Feng-Shuang","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Zhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.12.016_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.mcp.0000166490.92659.17","article-title":"Lymphocytes in pleural disease","volume":"11","author":"Dalbeth","year":"2005","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMra1403503","volume":"378","author":"Feller-Kopman","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","article-title":"US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample","volume":"151","author":"Taghizadeh","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.canlet.2020.12.016_bib4","first-page":"47","article-title":"Prognostic value of pleural effusion in patients with non-small cell lung cancer","volume":"3","author":"Sugiura","year":"1997","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1200\/JCO.2013.50.5453","article-title":"Prognostic impact of minimal pleural effusion in non-small-cell lung cancer","volume":"32","author":"Ryu","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2020.12.016_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","article-title":"Malignant pleural effusion: tumor-host interactions unleashed","volume":"186","author":"Stathopoulos","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib7","first-page":"1009","article-title":"Switching off malignant pleural effusion formation-fantasy or future?","volume":"7","author":"Spella","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.canlet.2020.12.016_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1183\/09031936.93.01040337","article-title":"Lymphocyte subsets in peripheral blood and pleural fluid","volume":"1","author":"Lucivero","year":"1988","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.canlet.2020.12.016_bib9","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/1078-0432.CCR-03-0239","article-title":"Characterization of effusion-infiltrating T cells: benign versus malignant effusions","volume":"10","author":"Atanackovic","year":"2004","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00029330-200804010-00001","article-title":"T lymphocytes in pleural effusion","volume":"121","author":"Yang","year":"2008","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.canlet.2020.12.016_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nature12079","article-title":"Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota","volume":"497","author":"Cebula","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.12.016_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.016_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/IR:32:1-3:155","article-title":"CD25+ CD4+ regulatory T-cells in cancer","volume":"32","author":"Linehan","year":"2005","journal-title":"Immunol. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2020.12.016_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2019.03.040","article-title":"Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion","volume":"452","author":"Wang","year":"2019","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.12.016_bib18","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/rccm.200504-588OC","article-title":"CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion","volume":"172","author":"Chen","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.imbio.2016.10.017","article-title":"Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease","volume":"222","author":"Budna","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.canlet.2020.12.016_bib20","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1158\/1535-7163.MCT-14-0448","article-title":"miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer","volume":"13","author":"Lv","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2020.12.016_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4161\/cbt.4.3.1644","article-title":"Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma","volume":"4","author":"DeLong","year":"2005","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.canlet.2020.12.016_bib22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1158\/1078-0432.CCR-08-2641","article-title":"CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion","volume":"15","author":"Qin","year":"2009","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells","volume":"194","author":"Iellem","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib25","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","article-title":"The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors","volume":"177","author":"Hirahara","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000121360","article-title":"Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors","volume":"31","author":"Mao","year":"2008","journal-title":"Onkologie"},{"key":"10.1016\/j.canlet.2020.12.016_bib27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ni.3211","article-title":"T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26","volume":"16","author":"Meller","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib28","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.immuni.2018.04.009","article-title":"Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis","volume":"48","author":"Hirota","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib29","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/s41467-020-16363-w","article-title":"TGF-beta signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer","volume":"11","author":"Perez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.12.016_bib30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","article-title":"IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor","volume":"29","author":"Chen","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.016_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib33","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.4049\/jimmunol.178.11.6730","article-title":"Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment","volume":"178","author":"Kryczek","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2020.12.016_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12272-019-01146-9","article-title":"T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer","volume":"42","author":"Chang","year":"2019","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.canlet.2020.12.016_bib36","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.1001728","article-title":"Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion","volume":"185","author":"Ye","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib37","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41598-018-35840-3","article-title":"Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patients","volume":"9","author":"Nieto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.12.016_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.12.016_bib41","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1073\/pnas.0710686105","article-title":"Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer","volume":"105","author":"Miyahara","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.12.016_bib42","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imm.12938","article-title":"The role of transforming growth factor beta in T helper 17 differentiation","volume":"155","author":"Zhang","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2020.12.016_bib44","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"184","author":"Su","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"T(H)17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib46","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","article-title":"T helper 17 cells promote cytotoxic T cell activation in tumor immunity","volume":"31","author":"Martin-Orozco","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ni.2945","article-title":"An antitumor boost to TH9 cells","volume":"15","author":"Quezada","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/0008-5472.CAN-14-2748","article-title":"Th9 cells: a novel CD4 T-cell subset in the immune war against cancer","volume":"75","author":"Vegran","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib49","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.85.18.6934","article-title":"Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity","volume":"85","author":"Uyttenhove","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.12.016_bib50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1084\/jem.169.1.363","article-title":"Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40)","volume":"169","author":"Van Snick","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00281-016-0601-1","article-title":"Th9 and other IL-9-producing cells in allergic asthma","volume":"39","author":"Koch","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.canlet.2020.12.016_bib52","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ni.1659","article-title":"Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset","volume":"9","author":"Veldhoen","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib53","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ni.1867","article-title":"The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","article-title":"Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells","volume":"33","author":"Staudt","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib56","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201207-1307OC","article-title":"Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion","volume":"186","author":"Ye","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00408-013-9474-4","article-title":"Recruitment and phenotypic characteristics of interleukin 9-producing CD4+ T cells in malignant pleural effusion","volume":"191","author":"Bu","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.canlet.2020.12.016_bib58","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4049\/jimmunol.1102840","article-title":"STAT6-dependent regulation of Th9 development","volume":"188","author":"Goswami","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","article-title":"Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells,","volume":"36","author":"Elyaman","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib60","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3389\/fimmu.2018.02901","article-title":"Th22 cells promote osteoclast differentiation via production of IL-22 in rheumatoid arthritis","volume":"9","author":"Miyazaki","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib61","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2020.12.016_bib62","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and tbet-dependent Th1 plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.12.016_bib64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib65","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood-2009-05-223768","article-title":"Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production","volume":"114","author":"Volpe","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2020.12.016_bib66","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/eji.201747183","article-title":"A catch-22: interleukin-22 and cancer","volume":"48","author":"Hernandez","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib68","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-07-4401","article-title":"Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2012.07.013","article-title":"Interleukin 22-producing CD4+ T cells in malignant pleural effusion","volume":"326","author":"Ye","year":"2012","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.12.016_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jmcb\/mjp004","article-title":"TGF-beta and 'adaptive' Foxp3(+) regulatory T cells","volume":"2","author":"Chen","year":"2010","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.12.016_bib71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta","volume":"194","author":"Nakamura","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib72","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.177.4.2331","article-title":"TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling","volume":"177","author":"Oida","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib73","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3892\/or.2014.3576","article-title":"Treg\/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis","volume":"33","author":"Yang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.12.016_bib74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1465-9921-12-77","article-title":"CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism","volume":"12","author":"Ye","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1164\/rccm.201310-1776OC","article-title":"Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion","volume":"189","author":"Lin","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1165\/rcmb.2015-0396OC","article-title":"Immune regulation of toll-like receptor 2 engagement on CD4(+) T cells in murine models of malignant pleural effusion","volume":"56","author":"Wu","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.canlet.2020.12.016_bib77","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/cbin.10485","article-title":"Toll-like receptor 4 signaling inhibits malignant pleural effusion by altering Th1\/Th17 responses","volume":"39","author":"Xu","year":"2015","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.canlet.2020.12.016_bib78","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0812530106","article-title":"IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.12.016_bib79","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20090246","article-title":"IL-9 as a mediator of Th17-driven inflammatory disease","volume":"206","author":"Nowak","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2020.12.016_bib80","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11427-016-0097-y","article-title":"Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism","volume":"59","author":"Lu","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.canlet.2020.12.016_bib81","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10585-005-2893-8","article-title":"ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention","volume":"22","author":"Alkhamesi","year":"2005","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2020.12.016_bib82","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1158\/0008-5472.CAN-08-2678","article-title":"Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis","volume":"69","author":"Slack-Davis","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib83","doi-asserted-by":"crossref","first-page":"L443","DOI":"10.1152\/ajplung.00120.2018","article-title":"Activated naive B cells promote development of malignant pleural effusion by differential regulation of TH1 and TH17 response","volume":"315","author":"Wu","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.canlet.2020.12.016_bib84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1165\/rcmb.2018-0201OC","article-title":"IL-17A-Producing gammadeltaT cells inhibit the formation of malignant pleural effusions","volume":"61","author":"Wei","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.canlet.2020.12.016_bib85","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/eji.201847685","article-title":"IL-10 promotes malignant pleural effusion in mice by regulating TH 1- and TH 17-cell differentiation and migration","volume":"49","author":"Wu","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2020.12.016_bib86","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/eji.202048574","article-title":"IL-10 promotes malignant pleural effusion by regulating TH 1 response via a miR-7116-5p\/GPR55\/ERK pathway in mice","volume":"50","author":"Zhai","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cei.12845","article-title":"Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer","volume":"186","author":"Hu","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib88","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.12.016_bib89","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-16-0431","article-title":"The emerging role of B cells in tumor immunity","volume":"76","author":"Tsou","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.016_bib90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.12.016_bib91","first-page":"9","article-title":"Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses","author":"Anfray","year":"2019","journal-title":"Cells"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520306662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520306662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:52:03Z","timestamp":1759593123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520306662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":91,"alternative-id":["S0304383520306662"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.12.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helper T cells in malignant pleural effusion","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}